作者
Christopher J Lettieri, Steven D Nathan, Scott D Barnett, Shahzad Ahmad, Andrew F Shorr
发表日期
2006/3/1
期刊
Chest
卷号
129
期号
3
页码范围
746-752
出版商
Elsevier
简介
Study objectives
The development of pulmonary arterial hypertension (PAH) can complicate many interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF). We sought to characterize the prevalence of PAH and its impact on survival in patients with advanced IPF.
Design
Retrospective analysis of consecutive IPF patients undergoing pretransplantation right heart catheterization.
Setting
Lung transplant and IPF referral center.
Methods
PAH was defined as a mean pulmonary artery pressure (mPAP) of > 25 mm Hg. We compared demographic, spirometric, 6-min walk test (6MWT) results, and survival outcomes between those with PAH and those without PAH.
Measurements and results
Seventy-nine patients were included in the study. PAH was present in 31.6% of patients (mean [± SD] mPAP, 29.5 ± 3.3 vs 19.1 ± 3.7 mm Hg, respectively). Those patients with PAH had a lower mean diffusing capacity of the …
引用总数
20062007200820092010201120122013201420152016201720182019202020212022202320246364054526062796069845855515048325732